In line with our observation, it has previously been shown that respiratory syncytial virus infection was associated with a defective humoral response, which correlated positively with the levels of CXCL10 [60], and that neutralizing CXCL10 improved ARDS [61]. This evidence concerns the gene CXCL10 and respiratory syncytial virus infectious disease.